Key points are not available for this paper at this time.
The complex etiology of neurological disorders is a major challenge to the identification of therapeutic candidates. Tackling brain vascular dysfunction is gaining attention from the scientific community, neurologists and pharmaceutical companies, as a novel disease-modifying strategy. Here, we provide evidence that at least 41% of neurological diseases and related conditions/injuries display a co-pathology of blood-brain and blood-spinal cord barrier alterations and dysfunctions, and we discuss why this figure may represent only a fraction of a larger phenomenon. We further provide clinical evidence that barrier status may contribute to pathological and functional outcomes in patients. Finally, we discuss drug candidates under development to repair brain barriers.
Building similarity graph...
Analyzing shared references across papers
Loading...
Sighild Lemarchant
Centre National de la Recherche Scientifique
Britta Engelhardt
University of Bern
Francesca Cicchetti
Centre hospitalier universitaire de Québec
Fluids and Barriers of the CNS
Inserm
University of Bern
Université Laval
Building similarity graph...
Analyzing shared references across papers
Loading...
Lemarchant et al. (Thu,) studied this question.
synapsesocial.com/papers/6a1c3085d54006be995faf9d — DOI: https://doi.org/10.1186/s12987-025-00688-z